SAFETY OF VEDOLIZUMAB, USTEKINUMAB AND TNF INHIBITORS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE MONOCENTRIC COHORT STUDY

Liesbeth Deroo  ¹     Laura Suarez  ²     Marie Truyens  ^{1, 1}     Jeroen Geldof  ¹     Soumaya Akhayad  ¹     Goedele Dewitte  ¹     Elien Glorieus  ^{1, 1}     Triana Lobaton  ^{1, 1    
1} Ghent University Hospital, Ghent, Belgium
² University Hospital of Santiago of Compostela, Santiago de Compostela, Spain

Topic
IBD

Session
PP 05 IBD (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)